Health · Healthcare & Policy · 1 hr ago
Neffy allergy nasal spray becomes available without a prescription in Canada
Neffy, an epinephrine nasal spray for severe allergic reactions, is now available without a prescription at Canadian pharmacies.
The change follows a national pharmacy regulators’ decision to classify its two-milligram dose as a Schedule II product.
It applies to adults and children weighing at least 30 kilograms, the group for whom Health Canada approved the spray in April.
Previously, a prescription was required in some provinces and territories.
People must speak with a pharmacist before receiving Neffy, and the pharmacist will provide counselling.
The spray offers caregivers another way to carry and use epinephrine as emergency treatment for a severe allergic reaction.
Younger children still have only EpiPen Jr. as an option, because Neffy’s one-milligram dose is not yet approved in Canada.
Neffy, an epinephrine nasal spray for severe allergic reactions, is now available without a prescription at pharmacies in Canada.
The National Association of Pharmacy Regulatory Authorities classified its two-milligram dose as a Schedule II product across Canada.
Customers must speak with a pharmacist, who will provide counselling before dispensing it without a prescription.
Health Canada approved the spray in April for adults and children weighing at least 30 kilograms.
- Who
- Neffy, an epinephrine nasal spray for severe allergies.
- What
- Its two-milligram dose is now available without a prescription at Canadian pharmacies. A pharmacist must counsel customers before dispensing it.
- When
- November 9, 2026.
- Where
- Pharmacies across Canada.
- Why
- NAPRA classified the dose as a Schedule II product, allowing it to be sold without a prescription in provinces and territories where one was previously required.
This story does not have two clearly opposing sides.
The U.S. Food and Drug Administration approved Neffy in the United States.
Health Canada approved the nasal spray for adults and children weighing at least 30 kilograms.
Neffy’s two-milligram dose became available without a prescription at pharmacies in Canada.
- Dose
- Two milligrams
- Classification
- Schedule II across Canada
- Minimum approved weight
- 30 kilograms (66 pounds)
- Younger patients
- The one-milligram dose is not yet approved in Canada; EpiPen Jr. remains the only option for patients weighing 15–30 kilograms